🔎 Trials Near Me

Akèy › Skleroz Amiotrofik Lateral › Kalifòni › San Francisco

Etid klinik pou Skleroz Amiotrofik Lateral nan San Francisco, CA

10 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Ap rekriteFaz 3
  • California Pacific Medical Center, San Francisco
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Ap rekriteFaz 2
  • Zydus US013, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07023835

ASSESS ALL ALS Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195

PREVENT ALL ALS Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861

Study of COYA 302 for the Treatment of ALS

Ap rekriteFaz 2/3
  • California Pacific Medical Center, San Francisco
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04363684

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Ap rekriteFaz 2
  • Sutter Health - California Pacific Medical Center Research Institute, San Francisco
Laj 18 a 75 · Tout sèks · Mizajou Jul 23, 2026 · NCT07142291

Clinical Procedures to Support Research in ALS

Ap rekriteEtid obsèvasyon
  • California Pacific Medical Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03489278

A Study of Ranolazine in ALS

Ap rekriteFaz 2
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06527222

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Ap rekriteFaz 1/2Volontè an sante akeyi
  • UCSF, San Francisco
Laj 18 a 80 · Tout sèks · Mizajou May 2, 2025 · NCT05395624

Etid Skleroz Amiotrofik Lateral nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.